Evaluation of Malignancy Probability Under Varying Exposure Intensities: Updated Efficiency Coefficients Based on Reanalyzed Atomic Blast Measurement Datasets and Healthy Tissue Absorption Levels
Keywords:
Radiation risk, malignancy probability, dose-rate effectivenessAbstract
Accurate estimation of malignancy probability under varying radiation exposure intensities remains a fundamental challenge in radiological protection, epidemiology, and clinical risk modeling. Traditional dose-response frameworks, largely derived from atomic bomb survivor data, have provided foundational insights into cancer risk; however, limitations in historical dosimetry systems and assumptions regarding dose-rate effectiveness have introduced uncertainties. This study presents a comprehensive re-evaluation of malignancy probability by integrating revised atomic blast measurement datasets with refined models of healthy tissue absorption. The research focuses on deriving updated efficiency coefficients that account for dose-rate variability, biological repair mechanisms, and non-tumor dose thresholds.
The methodological framework combines statistical modeling of epidemiological datasets with theoretical radiobiological principles, emphasizing nonlinear dose-response relationships and threshold-like effects. Reanalyzed dosimetry systems, including DS86 and DS02, are utilized to reassess exposure distributions and their correlation with cancer incidence patterns. The study incorporates evidence from both human cohorts and experimental models to establish a multi-scale understanding of radiation-induced carcinogenesis.
Key findings indicate that traditional linear extrapolation models may overestimate malignancy probability at low dose rates, particularly when biological adaptation and repair processes are considered. The derived efficiency coefficients demonstrate variability across exposure intensities, suggesting that a single universal dose-rate effectiveness factor is insufficient. The integration of healthy tissue absorption metrics further refines risk estimation by accounting for differential energy deposition across biological structures.
The study contributes to ongoing debates regarding low-dose radiation risk, offering a revised framework that enhances predictive accuracy while addressing inconsistencies in previous models. Implications extend to radiation protection guidelines, medical imaging practices, and environmental exposure assessments. Limitations include uncertainties in historical data reconstruction and variability across population-based studies. Future research should focus on integrating molecular-level biomarkers and advanced computational modeling to further refine risk predictions.
References
Anderson M, Storm HH. Cancer incidence among Danish thorotrast-exposed patients. J Natl Cancer Inst 1992;84:1318–25.
Berrington de Gonzales A, Darby S. Risk of cancer from diagnostic X-rays: estimation for the UK and 14 other countries. Lancet 2004;363:345–51.
Brooks AL, Eberlein PE, Couch LA et al. The role of dose-rate on risk from internally-deposited radionuclides and the potential need to separate dose-rate effectiveness factor (DREF) from the dose and dose-rate effectiveness factor (DDREF). Health Phys 2009;97:458–69.
Chen D, Wei LX. Chromosome aberration, cancer mortality and hormetic phenomena in areas of high background radiation in China. J Radiat Res 1991;32:46–53.
De Kruijff RM. FLASH radiotherapy: ultra-high dose rates to spare healthy tissue. Int J Radiat Biol 2020;96:419–23.
Fabrikant JI. Factors that modify risks of radiation-induced cancer. Health Phys 1990;59:77–87.
Finkel MP, Biskis BO, Scriber GM. The influence of strontium-90 upon life span and neoplasms of mice. In: Bugher JC, Coursaget J. Loutit JF. eds. Progress of Nuclear Energy. series VI, Vol. 2. London: Pergamon, 1959, 199–209.
Grant EJ, Brenner A, Sugiyama H et al. Solid cancer incidence among the life span study of atomic bomb survivors: 1958–2009. Radiat Res 2017;187:513–37.
Hsu WL, Preston DL, Soda M et al. The incidence of leukemia, lymphoma and multiple myeloma among atomic bomb survivors: 1950-2001. Radiat Res 2013;179:361–82.
Imanaka T. Summary and Analysis of the Calculation System for A-bomb Radiation Dose DS02 (in Japanese). Kyoto University Research Reactor Report KURRI-KR-114, 2005.
Ina Y, Tanooka H, Yamada T et al. Suppression of Thymic lymphoma induction by life-long low-dose-rate irradiation accompanied by immune activation in C57BL/6 mice. Radiat Res 2005;163:153–8.
International Commission on Radiological Protection (ICRP). 1990 Recommendation of the International Commission of Radiological Protection Publication 60. Annals of the ICRP, 21. Oxford: Pergamon, 1991.
Kaplan HS, Brown MB. A quantitative dose-response study of lymphoid-tumor development in irradiated C57 black mice. J Natl Cancer Inst 1952;13:185–208.
Kerr GD, Pace JV III, Mendelsohn E et al. Transport of initial radiations in air over ground. In: Roesch WC (ed). US-Japan Joint Reassessment of Atomic Bomb Radiation Dosimetry in Hiroshima and Nagasaki (DS86) vol. I. Hiroshima: Radiation Effects Research Foundation, 1987, 66–142.
Krestinina LY, Davis FG, Schonfeld S et al. Leukemia incidence in the Techa river cohort: 1953-2007. Brit J Cancer 2013;109:2886–93.
Little MP, Muirhead CR. Derivation of low-dose extrapolation factors from analysis of curvature in the cancer incidence dose response in Japanese atomic bomb survivors. Int J Radiat Biol 2000;76:939–53.
Little MP, Pawel D, Misumi M et al. Lifetime mortality risk from cancer and circulatory disease predicted from the Japanese atomic bomb survivor life span study data taking account of dose measurement error. Radiat Res 2020;194:259–76.
Morlier JP, Morin M, Monchaux G et al. Lung cancer incidence after exposure of rats to low doses of radon: influence of dose-rate. Radiat Prot Dosimetry 1994;56:93–7.
Nair MK, Rajan B, Jayalekshmi P et al. Background radiation and cancer incidence in Kelara, India-Karanagappaly cohort study. Health Phys 2009;96:55–66.
National Radiological Protection Boad, UK (NRPB). Risk of Radiation-induced Cancer at Low Doses and Low Dose Rates for Radiation Protection Purposes. Report, Vol. 6. 1995.
National Research Council USA (NCRP). Health effects of exposure to low levels of ionizing radiation BEIR V. Washington, DC: National Academy Press, 1990.
Ootsuyama A, Tanooka H. Threshold-like dose of local β-irradiation repeated throughout the life span of mice for induction of skin and bone tumors. Radiat Res 1991;125:98–101.
Ootsuyama A, Tanooka H. Zero tumor incidence in mice after repeated lifetime exposrues to 0.5 Gy of beta radiation. Radiat Res 1993;134:244–6.
Ozasa K, Culling HM, Ohishi W et al. Epidemiological studies of A-bomb radiation at RERF. Int J Radiat Biol 2019;95:879–91.
Pierce DA, Vaeth M. The shape of the cancer mortality dose-response curve for the A-bomb survivors. Radiat Res 1991;126:36–42.
Preston DL, Kusumi S, Tomonaga M et al. Cancer incidence in atomic bomb survivors, part III: leukemia, lymphoma, and multiple myeloma, 1950-1987. Radiat Res 1994;137:S68–97.
Roesch WC (ed). US-Japan Joint Reassessment of Atomic Bomb Radiation Dosimetry in Hiroshima and Nagasaki (DS86). Hiroshima: Radiation Effects Research Foundation, 1987.
Rowland RE, Stehney AF, Lucas HF. Dose-response relationships for female radium dial workers. Radiat Res 1978;76:368–83.
Rühm W, Azizova T, Bouffler S et al. Typical doses and dose rates in studies pertinent to radiation risk inference at low doses and low dose rates. J Radiat Res 2018;59:1–10.
Shimizu Y, Kato H, Schull WJ. Studies of the mortality of A-bomb survivors 9. Mortality 1950-1985: part 2. Cancer mortality based on the recently revised doses (DS86)1950-1985. Radiat Res 1900;121:120–41.
Shore R, Walsh L, Azizova P et al. Risk of solid cancer in low dose-rate radiation epidemiological studies and the dose-rate effectiveness factor. Int J Radiat Biol 2017;93:1064–78.
Tanooka H. Threshold dose-response in radiation carcinogenesis: an approach from chronic β-irradiation experiments and a review of non-tumour doses. Int J Radiat Biol 2001;77:541–55.
Tanooka H. Meta-analysis of non-tumour doses for radiation-induced cancer on the basis of dose-rate. Int J Radiat Biol 2011;87:645–52.
Tanooka H. Dose rate: A critical factor in determining the cancer risk of radiation at an environmental level. In: Mishra KP (ed). Biological Responses, Monitoring and Protection from Radiation Exposure. New York: Nova Science, 2015, 41–51.
Tanooka H. Dose rate problems in extrapolation of Hiroshima-Nagasaki atomic bomb data to estimation of cancer risk of elevated environmental radiation in Fukushima. Chapter 6. In: Suto S, Doss M, Tanooka H (eds). Fukushima Nuclear Accident: Global Implications, Long-Term Health Effects, and Ecological Consequences. New York: Nova Science, 2015, 101–13.
Thompson DE, Mabuchi K, Ron E et al. Cancer incidence in atomic bomb survivors. Part II: solid tumors, 1958–1987. Radiat Res 1994;137:S17–67.
Tubiana M. Radiobiologie. Paris: Hermann Medicine, 2008.
Tubiana M, Diallo I, Chavaudra J et al. A new method of assessing the dose-carcinogenic effects relationship in patients exposed to ionizing radiation. A concise presentation of preliminary data. Health Phys 2011;100:296–9.
United Nations Scientific Committee on the Effects of Atomic Radiation. Dose-response relationships for radiation-induced cancer. In: Sources and Effects of Ionizing Radiation: Genetic and Somatic Effects of Ionizing Radiation. Report to the General Assembly. New York: United Nations, 1986.
United Nations Scientific Committee on the Effects of Atomic Radiation. Influence of dose and dose-rate on stochastic effects of. In: Sources and Effects of Ionizing Radiation: Report to the General Assembly, Annex F. New York: United Nations, 1993.
United Nations Scientific Committee on the Effects of Atomic Radiation. Dose-response relationships for radiation-induced cancer. Biological effects at low radiation doses: models, mechanisms and uncertainties. In: Sources and Effects of Ionizing Radiation: Report to the General Assembly Annex I. New York: United Nations, 2000.
Upton AC, Randolph ML, Conklin JW. Late effects of fast neutron and gamma-rays in mice as influenced by the dose-rate of irradiation: induction of neoplasia. Radiat Res 1970;41:467–91.
Yamamoto O, Seyama T, Itoh H et al. Oral administration of trtiated water (HTO) in mouse. III. Low dose-rate irradiation and threshold dose-rate for radiation risk. Int J Radiat Biol 1998;73:535–41.
Young RW, Kerr GD (eds). Reassessment of the Atomic Bomb Radiation Dosimetry for Hiroshima and Nagasaki-Dosimetry System 2002 (DS02). Hiroshima: Radiation Effects Research Foundation, 2005.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Dr. Alexei V. Morozov, Dr. Elena S. Petrova
This work is licensed under a Creative Commons Attribution 4.0 International License.
Individual articles are published Open Access under the Creative Commons Licence: CC-BY 4.0.
